The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022

The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022

Abstract The Great Debate session at the 2022 Melanoma Bridge congress (December 1–3) featured counterpoint views from leading experts on five contemporary topics of debate in the management of melanoma. The debates considered the choice of anti-lymphocyte-activation gene (LAG)-3 therapy or ipilimum...

Full description

Bibliographic Details
Main Authors: Paolo A. Ascierto, Christian Blank, Alexander M. Eggermont, Claus Garbe, Jeffrey E. Gershenwald, Omid Hamid, Axel Hauschild, Jason J. Luke, Janice M. Mehnert, Jeffrey A. Sosman, Hussein A. Tawbi, Mario Mandalà, Alessandro Testori, Corrado Caracò, Iman Osman, Igor Puzanov
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Journal of Translational Medicine
Subjects:
Melanoma
Immunotherapy
Anti-PD-1
Targeted therapy
Adjuvant
Neoadjuvant
Online Access:https://doi.org/10.1186/s12967-023-04100-y

Internet

https://doi.org/10.1186/s12967-023-04100-y

Similar Items